Abstract
Purpose
A national survey was conducted in Japan to analyze the clinical characteristics of pellucid marginal corneal degeneration (PMD).
Methods
A questionnaire was sent to all members of the Japan Cornea Society requesting demographic and clinical findings on PMD patients who had been examined between 2008 and 2010. The presence of band-shaped peripheral corneal thinning, detected by slit-lamp biomicroscopy or by a pachymetric map, was set as the diagnostic criterion of PMD.
Results
Most of the participating facilities relied on either slit-lamp biomicroscopy or corneal topography as diagnostic tools for the detection of PMD. Data on 347 patients (579 eyes) were returned from the participating facilities for analysis, among which 162 eyes in 84 men and 24 women, with a median onset age of 37 years, met the PMD criteria. Of the 108 patients (162 eyes) with classical PMD, unilateral involvement was found in 25 % of patients (27 eyes). In 17 of the 27 eyes for which topographic findings for the contralateral eye were available, seven eyes were either keratoconus or had a suspected diagnosis of keratoconus. An association with allergic disease was found in 24 eyes (22.2 % of patients). Approximately half of the patients had 1.0 or better spectacle-corrected distance visual acuity, and only 5 % showed 0.1 or worse. The mean keratometric value was 45.7 diopters. On corneal topography, 100 eyes (61.7 %) showed the topographic “crab-claw pattern,” and the remaining eyes showed other patterns, including inferior steepening (22.2 %) and an irregular pattern (10.5 %).
Conclusions
We conducted the largest clinical survey of PMD to date and found a male predominance, a relatively high prevalence of unilateral involvement, and associated allergic diseases.
Similar content being viewed by others
References
Krachmer JH. Pellucid marginal corneal degeneration. Arch Ophthalmol. 1978;96:1217–21.
Jinabhai A, Radhakrishnan H, O’Donnell C. Pellucid corneal marginal degeneration: a review. Cont Lens Anterior Eye. 2011;34:56–63.
Kompella VB, Aasuri MK, Rao GN. Management of pellucid marginal corneal degeneration with rigid gas permeable contact lenses. CLAO J. 2002;28:140–5.
Sridhar MS, Mahesh S, Bansal AK, Nutheti R, Rao GN. Pellucid marginal corneal degeneration. Ophthalmology. 2004;111:1102–7.
Ambrosio R Jr, Wilson SE. Early pellucid marginal corneal degeneration: case reports of two refractive surgery candidates. Cornea. 2002;21:114–7.
Belin MW, Asota IM, Ambrosio R Jr, Khachian SS. What’s in a name: keratoconus, pellucid marginal degeneration, and related thinning disorders. Am J Ophthalmol. 2011;152:157–62.
Ertan A. Differentiating keratoconus and pellucid marginal degeneration. J Refract Surg. 2007;23:221–2.
Maguire LJ, Klyce SD, McDonald MB, Kaufman HE. Corneal topography of pellucid marginal degeneration. Ophthalmology. 1987;94:519–24.
Lee BW, Jurkunas UV, Harissi-Dagher M, Poothullil AM, Tobaigy FM, Azar DT. Ectatic disorders associated with a claw-shaped pattern on corneal topography. Am J Ophthalmol. 2007;144:154–6.
Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322.
Robin JB, Schanzlin DJ, Verity SM, Barron BA, Arffa RC, Suarez E, et al. Peripheral corneal disorders. Surv Ophthalmol. 1986;31:1–36.
Tzelikis PF, Cohen EJ, Rapuano CJ, Hammersmith KM, Laibson PR. Management of pellucid marginal corneal degeneration. Cornea. 2005;24:555–60.
Basak SK, Hazra TK, Bhattacharya D, Sinha TK. Unilateral pellucid marginal degeneration. Indian J Ophthalmol. 2000;48:233–4.
Kaushik S, Jain AK, Saini JS. Unilateral pellucid marginal degeneration. Eye (Lond). 2003;17:246–8.
Jain V, Nair AG, Jain-Mhatre K, Shome D. Pellucid marginal corneal disease in a case of atopic keratoconjunctivitis. Ocul Immunol Inflamm. 2010;18:187–9.
Fuchihata M, Maeda N, Toda R, Koh S, Fujikado T, Nishida K. Characteristics of corneal topographic and pachymetric patterns in patients with pellucid marginal corneal degeneration. Jpn J Ophthalmol. 2014;58:131–8.
Auffarth GU, Wang L, Volcker HE. Keratoconus evaluation using the Orbscan topography system. J Cataract Refract Surg. 2000;26:222–8.
Holland DR, Maeda N, Hannush SB, Riveroll LH, Green MT, Klyce SD, et al. Unilateral keratoconus: incidence and quantitative topographic analysis. Ophthalmology. 1997;104:1409–13.
Khor WB, Wei RH, Lim L, Chan CM, Tan DT. Keratoconus in Asians: demographics, clinical characteristics and visual function in a hospital-based population. Clin Exp Ophthalmol. 2011;39:299–307.
Wei RH, Zhao SZ, Lim L, Tan DT. Incidence and characteristics of unilateral keratoconus classified on corneal topography. J Refract Surg. 2011;27:745–51.
Oie Y, Maeda N, Kosaki R, Suzaki A, Hirohata Y, Hori Y, et al. Characteristics of ocular higher-order aberrations in patients with pellucid marginal corneal degeneration. J Cataract Refract Surg. 2008;34:1928–34.
Walker RN, Khachikian SS, Belin MW. Scheimpflug photographic diagnosis of pellucid marginal degeneration. Cornea. 2008;27:963–6.
Hassan Z, Nemeth G, Modis L, Szalai E, Berta A. Collagen cross-linking in the treatment of pellucid marginal degeneration. Indian J Ophthalmol. 2014;62:367–70.
Stojanovic A, Zhang J, Chen X, Nitter TA, Chen S, Wang Q. Topography-guided transepithelial surface ablation followed by corneal collagen cross-linking performed in a single combined procedure for the treatment of keratoconus and pellucid marginal degeneration. J Refract Surg. 2010;26:145–52.
Acknowledgments
This work was supported by Japanese Ministry of Health, Labour and Welfare (H22-Nanchi-Itsupan-199 and H26-Nannjinado (Nan)-Itsupan-072), Japanese Ministry of the Education, Culture, Sports, Science and Technology.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflicts of interest
J. Shimazaki, Fee for presentation (AMO, Alcon, Santen, Otsuka, Senju, Wakamoto); N. Maeda, Grant (Topcon), Fee for presentation (AMO, Alcon, B+L, Johnson & Johnson, HOYA, Oculus, Otsuka, Santen, Senyu, Tomey); O. Hieda, None; Y. Ohashi, None; A. Murakami, None; K. Nishida, Grant (Topcon, Menicon, Wacamoto, Senju, Otsuka, Rohto, Santen, Novartis, Alcon, Pfizer, HOYA, Bayer, MSD, Kowa, AMO), Fee for presentation (Senju, Otsuka, Santen, Novartis, Alcon, Pfizer, Hoya, Bayer, AMO, Boehringer-ingelheim, Seed, Chuosangio, Johnson & Johnson, Cibavision); K. Tsubota, None.
About this article
Cite this article
Shimazaki, J., Maeda, N., Hieda, O. et al. National survey of pellucid marginal corneal degeneration in Japan. Jpn J Ophthalmol 60, 341–348 (2016). https://doi.org/10.1007/s10384-016-0462-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-016-0462-0